Titlebook: Women in Biotechnology; Creating Interfaces Francesca Molfino,Flavia Zucco Book 2008 Springer Science+Business Media B.V. 2008 Gender.biodi

合群

含鐵

bifurcate

Egg Donation in the UK: Tracing Emergent Networks of Feminist Engagement in Relation to HFEA Policy ses, in relation to the sourcing and use of human eggs for biomedical research; specifically egg ‘donation’, for cell nuclear transfer (CNT). The paper will focus primarily on growing feminist criticism, in terms of (health) risks and other issues, such as concerns over the remit of public engagemen

肉體

strdulate

Technological Challenges: Asbestos Past Experiences, Nanoparticles Future Developmentsvement in the quality of life, but on the other hand, if technological processes are applied prior to their toxicity evaluation and safety testing, they may also become unfriendly. It is therefore necessary to implement any new technology only after it has undergone complete risk assessment studies.

類型

后退

Women’s Perceptions of Biotechnologies: The Case of Genetically Modified Foods in Switzerlandic’s perceptions of biotechnology, studies have found ‘publics’ rather than a single ‘general public’. Among other social classifications, women constitute a definable public to analyze, in particular in a feminist perspective. GM foods lie at the juncture of two essential questions of gender perspe

minimal

A Transdisciplinary Approach to Face the Plant Gene Transfer Technique: From Laboratory to Society stakeholders and citizens, towards the techniques for gene transfer and for genetically modified food and feed is the core of our study. The most innovative aspect of our research is a survey that specifically focuses on the scientific community wherescientists’ attitudes concerning the techniques

無聊點好

Outshine

Health Risks and Benefits from Biotechnology methods for the large-scale production of existing substances; is the basis for novel, highly sensitive and specific diagnostic tests; has developed new techniques in genetic engineering; is the basis for the development of new and safer vaccines, which are more effective and can be produced in lar